Physiologically relevant cellular models in drug development

Session Chair - Not Funded(s)

• AB

  Andreas Baudy, PhD

  Assoc. Principal Scientist
  Merck & Co., Inc., Pennsylvania, United States

Session Chair(s)

• 

  Catherine Tralau-Stewart, PhD

  Senior Director Alliances
  Takeda Pharmaceuticals, California, United States

Presentations:

• 10:00 AM – 10:30 AM

  A Precisely 3D Bioprinted and Functional Human Liver Tissue Model
  

  Thomas E. Angelini – University of Florida
• 10:30 AM – 11:00 AM

  A comparison of complex in vitro liver models to recapitulate signals associated with clinical DILI
  

  Aaron M. Fullerton, PhD, DABT – Genentech
• 11:00 AM – 11:30 AM

  Label-free imaging and deep learning analysis of patient-derived organoids to study tumor microenvironmental interactions
  

  Seungil Kim, PhD – Lawrence J. Ellison Institute for Transformative Medicine